These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9507810)

  • 21. Long interval between HCV infection and development of hepatocellular carcinoma.
    Castells L; Vargas V; Gonzalez A; Esteban J; Esteban R; Guardia J
    Liver; 1995 Jun; 15(3):159-63. PubMed ID: 7545775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of hepatocellular cancer during screening of 1125 patients with chronic hepatitis virus infection.
    Izzo F; Cremona F; Ruffolo F; Palaia R; Parisi V; Curley S
    J Chemother; 1997 Apr; 9(2):151-2. PubMed ID: 9176768
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of hepatocellular carcinoma type C and B by quantitation of serum HCV-RNA and HBV-DNA using branched DNA probe assay].
    Teramoto T; Iwabuchi S; Takatori M; Iino S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):787-95. PubMed ID: 7563876
    [No Abstract]   [Full Text] [Related]  

  • 24. [Role of chronic viral hepatitis in the development of hepatocellular carcinoma].
    Serov VV; Sekamova SM; Tanashchuk EL
    Arkh Patol; 2002; 64(5):60-4. PubMed ID: 12575544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into hepatitis B and C virus co-infection.
    Brass V; Moradpour D
    J Hepatol; 2009 Sep; 51(3):423-5. PubMed ID: 19596479
    [No Abstract]   [Full Text] [Related]  

  • 26. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis.
    del Olmo JA; Serra MA; Rodríguez F; Escudero A; Gilabert S; Rodrigo JM
    J Cancer Res Clin Oncol; 1998; 124(10):560-4. PubMed ID: 9829860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
    Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
    Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA; London WT
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C-related hepatocellular carcinoma: prevalence around the world, factors interacting, and role of genotypes.
    Mitra AK
    Epidemiol Rev; 1999; 21(2):180-7. PubMed ID: 10682256
    [No Abstract]   [Full Text] [Related]  

  • 30. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence of hepatocellular carcinoma in chronic viral hepatitis.
    Omata M; Takano S
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S153-4. PubMed ID: 7511067
    [No Abstract]   [Full Text] [Related]  

  • 32. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis.
    Hayashi PH; Di Bisceglie AM
    Med Clin North Am; 2005 Mar; 89(2):371-89. PubMed ID: 15656931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus and hepatocellular carcinoma.
    Colombo M; Fasani P; Romeo R
    Res Virol; 1997; 148(2):127-34. PubMed ID: 9108613
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.
    Fattovich G; Llovet JM
    J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis B and C viruses and hepatocellular carcinoma.
    O'Callaghan CJ; Edmunds WJ
    Trans R Soc Trop Med Hyg; 1997; 91(4):491-2. PubMed ID: 9373664
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevalence of hepatitis B and C virus markers in patients with hepatocellular carcinoma and outpatients with liver dysfunction in Mongolia].
    Shizuma T
    Kansenshogaku Zasshi; 2005 Oct; 79(10):824-5. PubMed ID: 16296329
    [No Abstract]   [Full Text] [Related]  

  • 37. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide.
    Maucort-Boulch D; de Martel C; Franceschi S; Plummer M
    Int J Cancer; 2018 Jun; 142(12):2471-2477. PubMed ID: 29388206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus and hepatocellular carcinoma.
    Giacosa A; Hill MJ
    Eur J Cancer Prev; 1996 Dec; 5(6):423-4. PubMed ID: 9061272
    [No Abstract]   [Full Text] [Related]  

  • 39. Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in Japan.
    Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Miyaaki H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Inokuchi K; Eguchi K
    Oncol Rep; 2006 Oct; 16(4):837-43. PubMed ID: 16969503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
    Kohli A
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.